NDC 67296-2300-01 - Hyoscyamine Sulfate SL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2300
- Requested NDC
- 67296-2300-01
- Package NDCs from labels
- 67296-2300-1, 67296-2300-2, 67296-2300-01
- Manufacturer
- Redpharm Drug
- Effective date
- 2026-10-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hyoscyamine Sulfate SL - Redpharm Drug | Redpharm Drug | 2026-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levsin | HYOSCYAMINE SULFATE | Viatris Specialty LLC | 32388e18-08de-455c-aad4-9c2264435f0f | 2025-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| Levbid | HYOSCYAMINE SULFATE | Viatris Specialty LLC | eb13c96f-319a-46f4-9955-ef5fa0a5f110 | 2025-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| NuLev | HYOSCYAMINE SULFATE | Viatris Specialty LLC | ae2a78b2-b811-11e2-9e96-0800200c9a66 | 2025-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | b8759036-81f9-4e31-8763-9e42cf78d9c5 | 2025-06-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Proficient Rx LP | 1f4b1ed7-bbba-4b2c-8139-b35cb428587d | 2025-06-01 | Warnings, Adverse reactions | F2R8V82B84 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Hyosyne | HYOSCYAMINE SULFATE | ATLANTIC BIOLOGICALS CORP. | 08ee0b24-a05b-451c-9d29-975570baed48 | 2025-05-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyosyne | HYOSCYAMINE SULFATE | ATLANTIC BIOLOGICALS CORP. | d022cde6-90c7-48b5-8022-cf7b76f4da19 | 2025-05-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Westminster Pharmaceuticals, LLC | 2b7d1604-3e95-4fc9-a65d-2c06ace16009 | 2025-04-21 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Westminster Pharmaceuticals, LLC | 9c0ae67b-7887-4820-ad77-8ea7261f9ed3 | 2025-04-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate ODT | HYOSCYAMINE SULFATE | Westminster Pharmaceuticals, LLC | 9429898d-301f-4ebc-8b1d-60595f76f1e3 | 2025-04-09 | Warnings, Adverse reactions | F2R8V82B84 |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2025-02-25 | Warnings, Adverse reactions | F2R8V82B84 |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2025-01-08 | Warnings, Adverse reactions | F2R8V82B84 |
| Donnatal | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Advanz Pharma (US) Corp. | c93cccdc-2f92-4cb3-9d14-06acdd51d94c | 2024-12-05 | Warnings, Adverse reactions | F2R8V82B84 |
| Donnatal | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Advanz Pharma (US) Corp. | 4dba30db-7979-455f-a225-24f0a04d744e | 2024-12-05 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | fdf1f194-2e18-403c-be28-7dd58739ead7 | 2024-11-13 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | e291da2e-a693-43f5-8cdd-2b8725371b79 | 2024-09-30 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Chartwell RX, LLC | 526399a7-03ea-4d09-8dcd-d5cb012ab5c5 | 2024-09-25 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Patrin Pharma, Inc. | 84be0ac5-f56f-4a06-a923-ca25252c5fef | 2024-09-04 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Patrin Pharma, Inc. | cd79f902-2a7b-4f3f-ac17-beaa254adfbc | 2024-09-04 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.